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ABSTRACT
Branched Chain Amino Acids and Risk of Type 2 Diabetes Mellitus:
A Literature Review
By
Alina A. Yemelyanov
November 20th, 2020

INTRODUCTION Type 2 diabetes mellitus (T2DM) is recognized as a major public health
problem in the modern world, with its prevalence increasing each year. Consistently poor
lifestyle habits — namely, nutritional excess coupled with sedentary behavior — are the leading
causes of obesity, which in turn leverages the gradual desensitization of cells to insulin, followed
by the onset of insulin resistance (IR) and the subsequent development of T2DM.
Countless studies and ongoing research have confirmed that nutrition plays a definitive role in
contributing to the development and onset of T2DM. However, in recent years, there has been
increasing controversy surrounding the role that branched-chain amino acids (BCAAs) may play
in influencing IR and the development of T2DM.
AIM To review existing literature regarding both the purportedly harmful and beneficial roles
and impacts of BCAAs on metabolic health, in order to better understand the contradictory
nature of BCAAs and their effects on IR and T2DM.
METHODS Relevant research, review articles and epidemiological studies spanning the
timeframe from 2004 to 2020 were collected, analyzed and summarized with the goal of
underscoring and delineating the conflicting roles of BCAAs.
RESULTS Evidence of beneficial effects of BCAAs includes enhanced muscle protein
synthesis, more efficient glucose homeostasis, increased satiety, better body composition and
improved body weight regulation. Evidence of harmful effects of BCAAs includes elevated
fasting concentrations of circulating BCAAs correlating with an increased risk of IR and T2DM
in human and rodent models.
DISCUSSION In spite of the various studies that have been undertaken to shed further light on
BCAAs, it still remains unclear whether they are simply markers of metabolic disturbances that
ultimately lead to the development of T2DM, or if they are, at least in part, the actual cause of
metabolic disturbances leading to T2DM. The general consensus amongst the scientific
community is that more research is needed on this topic.
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I.

INTRODUCTION

1.1. Type 2 Diabetes Mellitus as a Public Health Problem
Within the context of public health, type 2 diabetes mellitus (T2DM) has come to the
forefront as a prevalent chronic disease in our modern world, having led to significantly
escalating morbidity and mortality, while contributing to a large spike in associated healthcare
expenditures [5]. The prevalence of T2DM worldwide has been skyrocketing in recent years, to
the extent that it is now being recognized as one of the primary threats to human health and
wellness [14]. In the United States, this chronic disease has already taken a considerable toll on
public health, burdening approximately 9% of the entire population [2], while global estimates
indicate that upwards of 380 million adults worldwide suffer from T2DM; however, this number
is projected to continue rapidly increasing in prevalence over the course of the next 20 years [5].
In American adults, T2DM accounts for approximately 90-95% of all diagnosed cases of
diabetes, but the majority of all cases can be prevented or delayed simply by leading a healthier
lifestyle [16].
Over the long term, poor lifestyle factors play a determining role in influencing the
gradual development of T2DM: ongoing nutritional excess coupled with sedentary behavior
tend to lead to obesity, and this metabolic disorder becomes a major precursor to developing
T2DM, while acting to increase the secretion of insulin [2]. In fact, being overweight or obese is
considered to be the primary risk factor for T2DM, while leading a sedentary lifestyle makes
healthy weight maintenance less manageable, since cells gradually become less sensitive to the
effects of insulin, and glucose is not expended as readily for energy [9]. Moreover, obesity in and
of itself has become an escalating global health problem, posing a major risk factor for the onset
and development of metabolic syndrome, T2DM and other debilitating chronic conditions [7].
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Along with T2DM, the issue of obesity has become of far greater concern to public health in
recent years. Over the last four decades, its prevalence has radically increased. It is estimated that
in the United States alone, more than two in three adults are now considered to be overweight or
obese [15]. According to the latest data from the CDC, in 2017-2018, the age-adjusted
prevalence of obesity among U.S. adults was 42.4%, while the age-adjusted prevalence of severe
obesity among U.S. adults was 9.2% [18].
FIG. 1. Trends in age-adjusted obesity and severe obesity prevalence among adults
aged 20 and over: United States, 1999–2000 through 2017–2018

Hales, C., Carroll, M., Fryar, C., & Ogden, C. (2020, February 27).

However, apart from the primary conditions of overweight and obesity, several other
factors exist that markedly increase the risk for onset of T2DM, and these include family history,
race, ethnicity, age, polycystic ovarian syndrome (PCOS) in women, physical inactivity, and
excessive visceral fat distribution [9, 16]. Paradoxically, many obese individuals who carry a
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greater proportion of their adipose tissue subcutaneously rather than viscerally do appear to be
protected to a greater extent from IR and adverse metabolic responses [2].
FIG. 2. A Snapshot of T2DM in the US

Centers for Disease Control and Prevention. (2020, February 18).
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1.2. Etiology of Type 2 Diabetes Mellitus
T2DM is a condition characterized by abnormalities in carbohydrate, protein, and lipid
metabolism, with its most characteristic features consisting of hyperglycemia, or elevated blood
sugar levels, and dyslipidemia, which indicates abnormally high levels of lipids circulating in the
blood [14]. The biological pathway spurring the onset of T2DM involves insulin resistance (IR)
at its core. Insulin itself is required to consistently maintain glucose homeostasis [6]. The concept
of “insulin resistance” essentially refers to a marked decline in a target cell’s metabolic response
to insulin secreted by the pancreas; at the level of the entire organism, this translates to the
impaired ability of naturally-circulating or injected insulin to effectively lower blood glucose
levels [2]. IR has been recognized to play a major role in obesity-related metabolic disturbances,
since it is a “hallmark” of both obesity and sedentary behavior, and therefore is a key precursor
to developing T2DM [7, 2]. “Peripheral resistance” to insulin action is thought to act as a
primary mechanism in causing metabolic syndrome and, eventually, T2DM [1]. Additionally,
insufficient and dysregulated secretion of insulin by the pancreas is also believed to play a
contributing role in the occurrence of T2DM, along with the characteristic tissue insensitivity to
insulin action (IR) [5].
The significance of insulin sensitivity in regards to maintaining metabolic health has been
recognized for quite some time; however, until recent years, the specific mechanisms that may
induce IR largely remained unclear [6]. Today, this is no longer the case, since current research
has finally begun to shed some light on a variety of different mechanisms and potential causal
factors. The aforementioned lifestyle factors also play an important role and have a substantial
impact on the incidence of IR. “Strong environmental influences” triggering IR include
inadequate amounts of regular physical activity, as well as increased consumption of calorie-
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dense processed foods and beverages [5]. Additionally, several biochemical mechanisms are
known to be responsible for propagating IR, including carbohydrate metabolism, protein
metabolism, and fat metabolism [7]. Other factors implicated in IR include issues such as
systemic inflammation, physiological stressors, and oxidative stress, although IR appears to have
a significant heritable component, as well; moreover, large-scale human genetic studies
conducted in recent years have helped identify a more solid link between heredity and IR, while
also revealing a key role that reduced mitochondrial function may play in the onset of IR [5].
At present, obesity, metabolic syndrome and T2DM are widespread chronic disorders
affecting much of Western society, and the variety of factors involved in the development of
metabolic disease are complex [1, 2]. However, the current T2DM “pandemic” is largely thought
to be driven by the metabolic decline of those with prediabetes (preDM) into overt T2DM, since
the overwhelming majority of patients with preDM already exhibit some form of IR [5]. T2DM
itself is considered to be a taxing public health concern and a pervasive chronic disease that
presents an extensive burden to the healthcare system. This disease negatively impacts the body
on a broad scale, affecting multiple major organ systems, including the nerves, eyes, heart, blood
vessels, and kidneys. Long-term complications from T2DM tend to develop gradually, but with
time, they can become increasingly debilitating [9]. A variety of serious and potentially lifethreatening co-morbidities are associated with T2DM, including the likes of sleep apnea,
neuropathy, retinopathy, kidney failure, hearing impairment, slow wound healing, Alzheimer's
disease, and vascular morbidities, with devastating complications that lead to ischemic heart
disease and nearly 75,000 amputations each year in the US alone [1, 2, 9].
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1.3. Branched Chain Amino Acids as a Nutritional Factor
Branched chain amino acids (BCAAs), which consist of leucine, isoleucine, and valine,
are essential amino acids that are relatively abundant in dietary proteins, constituting up to 15%20% of total protein intake; thus, their concentration in blood serum increases after consumption
of a protein-rich meal [6, 7, 12]. The typical Western diet is able to provide an ample amount of
BCAAs, which means a deficiency is an “exceptionally rare” occurrence. In fact, metabolic and
physiological disorders associated with BCAAs usually stem from genetic disruptions, or they
originate as secondary disorders to other primary health problems, but not due to deficiency itself
[17]. Out of the three amino acids, leucine is the most abundant BCAA found in many dietary
proteins, accounting for over 20% of all protein derived from the average human diet [14].
BCAAs are considered to be “essential” amino acids because the body is incapable of
synthesizing them from other endogenous compounds at a rate that is essential for healthy
growth and functioning, which is why it is necessary to obtain them from a balanced diet [10,
14]. They are referred to as “branched” because this is a descriptive term derived specifically
from the structure of their side chains [17].
BCAAs are critical nutrient signals that either directly or indirectly impact the
metabolism, supposedly by influencing several catabolic and synthetic “cellular signaling
cascades” that help produce altered phenotypes in mammals [6, 3]. Amino acids such as BCAAs
are essential for protein synthesis. Therefore, along with the hormone insulin, BCAAs perform
the role of anabolic signals, which can alter the growth of energy-consuming tissues, including
skeletal muscle and adipose tissue [6], as well as reduce protein breakdown, although the precise
mechanisms for this function remain unknown [4].
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The effects of these amino acids have been studied on a number of disorders, most
notably trauma, cancer, sepsis, kidney failure, liver cirrhosis, and burn injury. Supplementation
with BCAAs has been alleged to fuel anabolic pathways, consequently helping to mitigate
exercise-induced fatigue, promote better wound healing, stimulate insulin production, alleviate
cachexia – also known as muscle wasting syndrome – and prevent or treat signs of hepatic
encephalopathy caused by severe liver damage [11]. Research has even been undertaken to
evaluate the effects of BCAA supplementation on immune response and exercise-induced
inflammation, especially as it pertains to strenuous endurance events, such as triathlons and
ultramarathons [20]. Although BCAAs are believed to have beneficial health and metabolic
properties, there is still no definitive scientific consensus regarding their therapeutic
effectiveness, as well as their safe and effective use as nutritional supplements [11]. Despite this,
BCAAs have generated substantial research interest in the scientific community due to their
emerging roles as potential biomarkers of metabolic disease [14].
FIG. 3.

Andrews, R. (2019, December 30).
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FIG. 4.

Petre, A. (2016, November 25).

II.

REVIEW OF THE LITERATURE

2.1. The Advantages of BCAAs
Multiple studies have demonstrated various positive effects offered by BCAAs on both
animal and human models. Additionally, limited studies have helped illustrate the essential roles
that BCAAs play within the physiological regulation of many processes, apart from basic
nutrition, and this especially appears to hold true for their role in impacting disease progression
[13]. The results from several interventional studies have also proposed that increasing
consumption of BCAAs in the diet should leverage an overall positive effect on the parameters
associated both with obesity and T2DM, such as satiety, body composition, and blood sugar
levels [4].
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Because BCAAs – and leucine especially – are such effective protein building blocks,
they have garnered substantial interest from the fitness community in recent years, specifically
due to their positive effects on enhanced muscle protein synthesis [3]. Not only do BCAAs serve
as “substrates” for protein synthesis, they actually stimulate protein synthesis while
simultaneously inhibiting proteolysis, or the breakdown of muscle protein [11]. While exhibiting
a dominant role in regulating and stimulating protein synthesis, leucine has been identified as a
particularly important nutrient signal [3, 4]. It has also been recognized as an active stimulator of
both cellular metabolism and mitochondrial biogenesis in “metabolically consequential” cell and
tissue types, such as adipose tissue and skeletal muscle [3, 4]. In other words, apart from their
anabolic effects, BCAAs may also help proliferate mitochondrial content in both skeletal muscle
and fat cells, thus possibly enhancing oxidative capacity and making cells more metabolically
efficient [3]. A few studies have also indicated that supplementing with BCAAS before and/or
after working out can help reduce muscle soreness that typically follows exercise. Although the
specific mechanism responsible for BCAAs’ protective effects against exercise-induced soreness
and muscle damage is still unclear, it is suspected that leucine in particular may stimulate protein
synthesis, while BCAAs may be involved in helping suppress exercise-induced protein
breakdown [19].
Furthermore, a positive association has been demonstrated between using BCAA
supplementation or consuming a BCAA-rich diet and subsequent metabolic health; essentially,
this means that elevating BCAA levels in the body appears to lead to positive health effects,
improving such metabolic parameters as glucose homeostasis, satiety, muscle protein synthesis,
body composition and body weight regulation [6, 7]. This has been demonstrated in both human
and animal studies [7]. The results from Zhao et al.’s systematic review managed to confirm that
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a BCAA-rich diet might confer a “weakly positive” impact on peripheral BCAA levels, which
can most frequently be explained by the reduced glycemic load inherent in high-protein diets [7].
Insufficient levels of BCAAs in the diet are nonetheless associated with impaired growth and
protein wasting. In fact, studies on human subjects have shown that decreased BCAA levels may
adversely affect brain function by negatively impacting the synthesis of neurotransmitters.
Therefore, BCAA supplementation does appear to be a sensible option in disorders that are
characterized by dwindling BCAA levels, which occur during such illnesses as liver cirrhosis,
chronic renal insufficiency, and urea cycle disorders [11].
Both direct and indirect mechanisms for some of BCAAs’ positive effects have been
suggested; for instance, leucine appears to directly affect the hypothalamic and brainstem
processes that are involved in feelings of satiety and reduced hunger. In fat deposits and in the
gastrointestinal tract, BCAAs appear to regulate the release of both appetite-stimulating and
appetite-suppressing hormones, such as ghrelin and leptin, respectively, and this can potentially
impact food intake and blood sugar levels [4]. Additionally, BCAAs in general have also been
hypothesized to help enhance overall cell metabolism and improve cellular energetics, after they
were shown to activate several regulatory targets involved with increased mitochondrial
metabolism [3].
2.2. The Disadvantages of BCAAs
Despite the variety of positive findings purporting the benefits of BCAAs on metabolic
health, numerous studies have indicated that these amino acids appear to have a notable
downside: along with blood sugar, insulin and certain inflammatory markers, elevated fasting
concentrations of circulating BCAAs correlate with an increased risk of IR and T2DM in both
humans and in some rodent models [4]. Although the exact underlying mechanisms of the
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relationship between BCAAs and T2DM progression, severity and prediction have yet to be fully
identified, an imbalance of amino acids – in addition to hyperglycemia and dyslipidemia – may
play a pathogenic role, since this imbalance is also a characteristic trait of the diabetic state [14].
In fact, it has been established that in insulin resistant states of obesity, plasma
concentrations of amino acids, and BCAAs in particular, tend to be elevated. Previous studies
employing metabolomics approaches and extensive metabolic profiling have consistently
reported that obese, insulin resistant or T2DM rats and humans both exhibited a disturbance of
normal amino acid metabolism, as well as an increased level of circulating BCAA-related
metabolites [4, 6, 7]. These findings overlap with studies showing that in experimental settings,
an influx of amino acids induces IR, similar to what is witnessed with lipid administration.
Recently, growing evidence has demonstrated an interaction between BCAAs and excess fat, as
well as between BCAAs and excess protein consumption. More specifically, adding BCAAs into
a high-fat diet contributes to the onset of impaired glucose homeostasis and IR, both of which
can occur independently of body weight [14]. Additionally, several contemporary studies have
come to the conclusion that consuming high levels of protein, which is entirely composed of
amino acids, is correlated with IR, T2DM, and increased mortality in both mice and humans,
while low protein (LP) diets appear to be associated with better metabolic health and increased
survival [15].
BCAAs are considered to be particularly sensitive to insulin action, as their metabolism
has been observed to be “profoundly altered” during insulin resistant states [1]. IR is often
associated with mitochondrial dysfunction and stress signaling [14]. These two processes are
energy sources and believed to be triggered by an abnormal BCAA metabolism in obesity, which
results in an accumulation of toxic BCAA metabolites, especially in insulin resistant subjects [6,
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14]. Indeed, while it has been established that BCAAs are undoubtedly necessary for protein
synthesis, some of the intermediates formed during their catabolism can actually be toxic at high
concentrations. Therefore, the efficient disposal of excess BCAAs from the body is in fact vital
for maintaining homeostasis and overall metabolic health [19]. Circulating levels of BCAAs tend
to be elevated in individuals with obesity, impaired fasting glucose levels and T2DM [4, 14],
although morbidly obese individuals who have elevated levels of BCAAs usually see these levels
normalize after undergoing gastric bypass surgery [14].
Due to their prevalence in the aforementioned metabolic disturbances, BCAAs are
believed to have the potential to predict development of T2DM and obesity, while being
associated with worse metabolic health overall, as well as the likelihood for future onset of IR or
T2DM [4, 13, 14]. Levels of BCAAs also correlate well with weight loss outcomes and have
been shown to diminish in both rodents and humans consuming low protein diets [15]. In
addition, high levels of circulating BCAAs at baseline have also been directly linked to a
heightened risk for cardiovascular diseases (CVDs). Although this harmful relationship may be
counteracted by implementing a Mediterranean-style diet intervention to lessen the burden of
pathophysiological processes and stimulate cardio-protective effects, BCAAs can apparently
function as biomarkers to predict CVD outcomes, as well [13]. Because of BCAAs’ great
potential to function in the role of predictive biomarkers, their metabolic pathways may be able
to serve as possible targets for the treatment of T2DM in the future [14].
BCAA metabolism is believed to be disrupted in other circumstances that typically
involve IR, as well, such as liver and kidney dysfunction. However, despite the insulin resistant
state, BCAA plasma levels in these conditions are still lower than in healthy subjects, which
indicates that these organs may be involved in maintaining healthy BCAA blood concentrations
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[1]. Furthermore, recent research studies have performed various investigations on BCAAs and
IR, as well as on diabetes risks across different races, ethnicities, sexes, etc. They have been able
to demonstrate the positive association between increased circulating BCAAs and IR in obese or
diabetic patients. Nevertheless, these results are controversial, as they have shown notable
discrepancies in BCAA levels depending on variations in ethnicities, races, sex, gene
expressions, dietary patterns and distinct tissues. At the same time, there is a general dearth of
studies focusing on innately “phenotypic and genetic factors” that could also have an influence
on BCAA levels [7].
2.3. The Metabolism of BCAAs
The catabolism of BCAAs is a complex process that requires multiple enzymatic steps,
most of which take place in the mitochondria of cells after protein has been ingested [11, 17].
The first two steps of this catabolic pathway are the same for all three BCAAs [20]. However,
unlike all other amino acids, which are primarily catabolized in the liver [19], the initial step of
BCAA catabolism does not take place in the liver at all, and this is due to low hepatic activity of
branched-chain-amino-acid aminotransferase (BCAT), which is the very first enzyme activated
in the BCAA catabolism pathway [11]. The initial site of the majority of BCAAs’ catabolic
processes is located in skeletal muscle, because of high BCAT activity in these specific tissues
[11]. The fact that BCAAs’ first catabolic step entirely bypasses the liver for their primary
catabolism to occur in the skeletal muscle makes BCAAs fairly unique, in comparison to other
amino acids. In fact, approximately 50% of all amino acid uptake in the skeletal muscles consists
of BCAAs, since leucine, isoleucine and valine are able to avoid “first pass metabolism.” This
metabolic concept refers to substrates being metabolized entirely by the liver immediately
following their absorption from the intestine [17]. This bypass of first pass metabolism results in
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BCAA concentrations rapidly increasing in systemic circulation, thus making them readily
available to cells and tissues outside the liver. This phenomenon provides the BCAA-based
nutritional formula with a distinct advantage, since these amino acids are much more efficient at
targeting extrahepatic tissue, such as the brain and skeletal muscles, and can thus be oxidized in
skeletal muscle itself [11, 19].
Research indicates that BCAAs may contribute to energy metabolism during exercise, in
the form of both substrates and energy sources [19]; additionally, exercise not only significantly
increases energy expenditure, but also substantially promotes the oxidation of BCAAs
themselves [19, 20]. This is the case because exercise has an overall “profound effect” on protein
metabolism: if a workout is intense enough, it will invariably result in a net loss of muscle
protein, either due to high muscle breakdown, reduced protein synthesis, or even both at once.
When this is happening, some amino acids – primarily BCAAs – are oxidized as a source of fuel,
and byproducts of this oxidative process, such as ammonia, are produced in proportion to
exercise intensity [20].
The particular extrahepatic metabolism of BCAAs has been identified as a significant
factor in the pathophysiology of a variety of multi-faceted diseases, such as metabolic syndrome,
cancer, and hepatic disease [7]. It is believed that impaired BCAA catabolism, especially in
adipose tissue, contributes to the rise of BCAAs witnessed in obesity and in insulin resistant
states [14]. Conversely, given the fact that skeletal muscle is the “largest site of glucose
disposal,” while also considering that loss of muscle mass may ultimately contribute to metabolic
syndrome and T2DM, it seems possible that elevated circulating BCAA levels might actually
reduce the risk of glucose intolerance and subsequent metabolic disease [3].
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FIG. 5. This complex diagram illustrates BCAAs’ balance & their multiple roles via the PI3K-AKT-mTOR
signaling pathway. BCAAs play critical roles as nitrogen donors for several different amino acids, as well
as nutrient signals in numerous metabolic functions through special signaling pathways, especially via
the PI3K-AKT-mTOR pathway. BCAA metabolic imbalances may cause various health issues, such as
diabetes & cancer [13].

Nie, C., He, T., Zhang, W., Zhang, G., & Ma, X. (2018).
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III.

TWO PERSPECTIVES ON BCAAS

An ongoing debate has been taking place surrounding the interplay of BCAAs, insulin
resistance, and type 2 diabetes mellitus. Current evidence suggests that the metabolic effects of
BCAAs can be either beneficial or detrimental with respect to the risk of T2DM, but neither
effect has been established as an absolute in all cases. In other words, the metabolic effects of
BCAAs are similar to that of a double-edged sword.
Research conducted on the effect of circulating serum BCAA concentrations and
IR/insulin metabolism has demonstrated contradictory and somewhat controversial findings:
while some studies indicate that impaired BCAA metabolism and increased plasma levels of
BCAAs are associated with a higher risk for IR or hyperglycemia and subsequent T2DM, other
studies demonstrate that increased plasma BCAA concentrations have no effect on insulin
sensitivity whatsoever [12]. Some research has shown that close associations exist between
BCAAs and plasma glucose levels, and it has also been widely demonstrated that BCAAs
“upregulate glucose transporters and activate insulin secretion.” Nonetheless, several researchers
have proposed the notion that excessive BCAA intake could do more harm than good by
contributing to the inhibition of insulin signaling [11]. The limited range of studies that have
evaluated the association between dietary BCAA intake and the risk of T2DM have yielded
similarly inconsistent results. One study claims that a higher intake of BCAAs is associated with
a decreased risk of T2DM, while another study argues that high consumption of BCAAs does in
fact increase the risk for development of T2DM [12]. Indeed, it appears that the effects of
BCAAs are something of a double-edged sword.
This paradoxical role of BCAAs’ impact on metabolism naturally raises some questions
and concerns, especially when considering the fact that BCAAs are a popular nutritional
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supplement for those who are active in the bodybuilding and fitness communities. Because
BCAAs are most prominent for raising protein synthesis through the modulation of protein
translation, they are especially appealing both to resistance and endurance athletes alike in their
potential to aid with accelerated recovery, muscle hypertrophy, and lean body mass retention [3].
Despite the potentially beneficial associations between circulating BCAAs, improved
cellular energetics, and increased skeletal muscle mass, elevated circulating BCAA levels have
nonetheless been detected during metabolic pathologies that include IR and T2DM [3]. Yoon
confirms that the perceived link between levels of circulating BCAAs, insulin resistant obesity,
and T2DM has prompted speculation regarding whether BCAA levels can be viewed as a
predictor for future IR or T2DM, in spite of the allegedly beneficial effects of a BCAA-rich diet
and BCAA supplementation [6]. In light of the given information, there are two divergent
perspectives on the topic of BCAAs and their impact on metabolic health:
a) increased plasma BCAAs are the cause of IR and T2DM, or
b) increased plasma BCAAs are the result of IR and T2DM, and can thus serve as
effective biomarkers for metabolic risk.
Therefore, when looking at the big picture regarding BCAAs, it is important to consider
whether these amino acids are in fact causative or predictive of IR, as well as what their potential
role in insulin signaling may be [6]. It is also necessary to understand whether BCAA-rich diets
are “harmful, helpful or neutral with respect to insulin and glucose homeostasis” [4, 6]. Based on
already available data, consistent correlations do seem to exist between elevated circulating
levels of BCAAs and metabolic disease in humans, especially in regards to IR [3]. Thus, it is
crucial to identify accurate parameters or biomarkers that can most effectively reflect IR and
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metabolic risks, in order to better understand the inherent mechanisms underlying obesity-related
complications [7].
Lynch & Adams suggest that “perturbations in BCAA levels probably reflect the insulin
resistant and T2DM ‘pathophenotypes,’ and BCAAs themselves are probably not necessary or
sufficient to trigger disease” [4], although BCAA levels have been found to be elevated in the
blood of obese, insulin resistant humans and rodents on more than one occasion [15]. As is the
case with many different metabolites in the process of metabolic disease, such as glucose and
lipids, BCAA accumulation does appear to correlate with and might have some predictive value
of metabolic aberrations [3]. Consistent observations in cross-sectional and prospective human
studies, along with limited other studies, have also suggested that BCAA supplementation
actually leads to a “deterioration of insulin sensitivity” [4]. According to Yoon, elevated BCAA
levels stimulate an intricate metabolic pathway involving a nutrient sensing complex, and this
results in IR and other metabolic disorders [6]. It has also been hypothesized that elevated
circulating BCAAs observed in an insulin resistant state may result from dysregulated BCAA
degradation [3]. However, the results of recent investigations demonstrate that even in normalweight subjects, a definitive association between increased blood levels of BCAAs and IR was
detected, suggesting that perhaps the increased concentration of BCAAs found in obese subjects
is likely related to IR itself, rather than obesity [1].
The idea that elevated levels of circulating BCAAs have a strong relation to metabolic
disease, especially IR, is not necessarily under dispute. However, the interplay between
circulating BCAAs and metabolic disease is indeed a highly complex process, so it has not yet
been fully understood or analyzed. In fact, elevated circulating BCAAs may be a product of
multiple factors [3]. Findings from the population-based cohort study conducted by Asghari et al.
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on a sample of residents from a district of Iran’s capital, Tehran, indicate that a high intake of
BCAAs is indeed related to a greater risk of IR. In addition, out of the three BCAAs, a higher
intake of leucine and valine, in particular, had a significant association with a higher risk for
incident IR. Nevertheless, no major association was established between dietary BCAA intake
and the development of hyperinsulinemia and pancreatic beta-cell dysfunction [12]. In fact, the
direct influence of a particular diet on BCAA levels and subsequent IR is not yet recognized [7].
Gannon et al.’s findings agree with this notion, that despite being “essential” in nature, dietary
protein intake does not appear to correlate with circulating BCAA levels. According to one of the
reports on human studies that they summarized, it was clearly specified that while protein intake
was linked with select amino acids (valine, phenylalanine, tyrosine, and glutamine), it was not in
any way associated with actual IR. Consequently, it is believed that dysregulated BCAA
catabolism may be the principal cause of elevated circulating BCAA concentrations observed in
diabetics [3].

IV.

DISCUSSION

It still remains unclear whether BCAAs are simply markers of the metabolic disturbances
that ultimately lead to the development of T2DM, or if they are, at least in part, the actual cause
of metabolic disturbances leading to T2DM. In other words, both the pros and cons of BCAAs
must continue to be carefully weighed and thoroughly analyzed. Gannon et al. propose two
alternative theories: Under more or less “ideal” conditions of metabolic homeostasis or energy
deprivation, BCAAs – and leucine in particular – may be capable of supporting improved
“metabolic phenotypes,” while also promoting beneficial metabolic properties such as greater
mitochondrial content, better insulin sensitivity and glucose uptake, and increased muscle
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preservation. However, under conditions of “chronic excess energy,” cells – especially
adipocytes – seem to lose their ability to efficiently degrade BCAAs, which can subsequently
lead to an accumulation of BCAAs and related metabolites, both intracellularly and in overall
circulation [3].
Irrespective of any theories, there remains a dearth of knowledge regarding the full
potential of BCAAs, as well as their complete impact on pathways of metabolism that affect
pancreatic alpha-cell function [14]. Additionally, hypotheses surrounding BCAAs and their
effects on metabolic outcomes are still shrouded with speculation. Considering the vast diversity
and varied possibilities of experimental models, which can range from basic cell lines to actual
animal studies, plenty of discrepancies still abound in the literature – for instance, in many cell
studies that have been described so far, amino acid concentrations in the cells are often in
substantial excess of AA concentrations that are physiologically attainable in mammals [3].
Further investigation is still required to better understand the variable reports on all of BCAAs’
impacts, ranging from improving glucose utilization to inducing IR [11]. This is especially true
because current experiments are scientiﬁcally sound, but they are nonetheless far removed from
reality – in other words, the context in which humans typically consume BCAAs, both in terms
of their amounts and sources. This is compounded even more when considering the vast array of
behaviors and food chemicals with which BCAAs are usually consumed [3].
To date, no large-scale population-based studies investigating the relationship between
dietary BCAA intake, the risk of IR and pancreatic beta-cell dysfunction have been conducted,
either [12]. Moreover, despite many years of ongoing research, the exact mechanisms linking IR
and obesity-related metabolic complications also have yet to be fully established and understood
[7]. Furthermore, much of the effects of BCAAs appear to manifest themselves on an
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individualized, case-by-case basis. Based on much of the data that currently exists, it appears that
BCAAs’ influences on health and metabolism are primarily dependent upon experimental model,
energy equilibrium, and tissue type [3]. For instance, elevated BCAA levels and their connection
with IR appear to be race-dependent, at least to some extent. Zhao et al. advise that it would be
ideal for future research studies to extend their sample sizes to include subjects of different races,
in order to better validate the varied findings on BCAAs. In regards to gender differences, many
studies indicate that obese men display higher BCAA levels and a stronger positive correlation
with IR compared to female test subjects [7]. According to one of the human studies reports
summarized by Gannon et al., individual BCAAs exhibited “sex- and obesity-dependent
associations,” and additionally, they specifically required abdominal obesity to be present in
women to exert a tangible metabolic effect [3]. Meanwhile, in the “Young Finn’s Study,”
BCAAs were directly linked with IR in men but not in women, and several other amino acids
showed no association with IR whatsoever [21]. This suggests that future studies should consider
gender differences more carefully in the process of study design and data analysis. Zhao et al.
confirm that diverse racial profiles and gender differences – and even genetics – can have
substantial effects on BCAA levels and IR, so these variables should also be accounted for by
conducting research with larger and more diverse study populations [7].
Gannon et al. echo this sentiment, concurring that the role individual BCAAs play in the
development of IR remains unclear, based on all the data that already exists. It is possible that
excess intake of calories in general, coupled with excessive lipid consumption and elevated fat
mass in the body, may contribute to the initial onset of metabolic dysregulation, which in turn
leads to greater BCAA accumulation. This hypothesis is supported by the fact that many athletic
populations tend to consume excess protein and/or BCAAs, yet they do not go on to develop IR
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or other metabolic diseases [3]. What’s more, the role of obesity during the process of BCAA
accumulation is not apparent in all populations. Likewise, the accumulation of circulating
BCAAs is not detected in every experimental model of obesity, but this may be due to
differences among the experimental models themselves. Nonetheless, the accumulation of
BCAAs during severe IR is a fairly consistent observation, although based on existing research
interpretations, it seems as though “depressed BCAA catabolic enzymes” may very well be a
contributing factor in the accumulation of BCAAs, and may thus be altered by energy balance
[3]. Shimomura et al. note that more follow-up studies on BCAAs are necessary on several other
fronts. The most effective ratio for consuming the three BCAAs in a way that allows to reap all
their benefits remains unknown. As they point out, a variety of interesting observations have
been made on BCAAs, but future studies should be designed with the intention of clarifying the
mechanisms responsible for their positive post-workout effects, as well as identifying the
proportion in which each BCAA should be consumed to maximize their collective exerciseboosting properties. [19].

V.

CONCLUSION

Considering the assortment of data that is currently available, it may be safe to surmise
that the effect of dietary BCAAs on T2DM risk most likely hinges on sex and individual states of
energy balance. Perhaps the real issue in many cases isn’t so much the “fault” of BCAAs
themselves, but rather, different individuals’ pathologically-prone metabolic backgrounds. It is
possible that BCAAs aren’t truly the cause of metabolic abnormalities, but their accumulation is
simply one of the consequences of a metabolism that is already ailing due to many other more
severe health factors.
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For example, given ample data both from health and athletic populations, it appears that
dietary sources of BCAAs are unlikely to be “independently suﬃcient” to actually cause
metabolic disease in “otherwise healthy” populations. In other words, BCAAs and overall
protein consumption on their own are incapable of independently spurring the onset of metabolic
disease plus the dysregulated BCAA metabolism associated with it [3]. It’s also possible that
other metabolic and health factors might align more closely with elevated BCAAs than IR or
T2DM. For instance, obesity may track more strongly with elevated BCAAs than either T2DM
or metabolic syndrome. In a study conducted with 1,302 participants ages 40-79, higher BCAA
levels went hand in hand with male sex, older age and metabolic syndrome, as well as with
obesity, hypertension, dyslipidemia, cardiovascular risk and uric acid [21]. This further
underscores the depth of complexity of elevated BCAAs as a metabolic marker, as well as just
how many other factors are entwined with this one.
In spite of gaps in the literature, Zhao et al. contend that BCAAs can be used as a
valuable biomarker of IR, as well as a potent predictor for T2DM risks down the line. Apart from
reflecting an insulin resistant state, BCAAs may also provide feedback regarding various
pharmacological effects of drug interventions. Thus, they could serve as a useful biomarker to
help monitor for an early response to therapeutic interventions in T2DM patients. Regularly
measuring BCAA levels might also help more effectively capture the entire course of disease
progression, beginning with obesity and crossing into IR, T2DM and subsequent efficacy of drug
treatments [7].
As Yoon and Holeček concluded in their respective reviews, whether elevated BCAA
levels are merely markers of IR or a dysfunctional metabolism, or if they actually contribute to
IR and other metabolic abnormalities remains an uncertainty for the time being, but this topic is
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progressively gaining traction and attracting more research interest [6, 11]. With this in mind, the
entire scope of BCAAs’ potential impacts and effects on metabolic health should undoubtedly be
determined well in advance, prior to making any health-oriented decisions to use them on obese
subjects and patients with T2DM [11].
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